Yale Medicine School Endocrinologist Provides Update on Hypercalcemia of Malignancy, A Complication for Cancer Patients
April 15, 2022
April 15, 2022
NEW HAVEN, Connecticut, April 15 (TNSJou) -- Yale School of Medicine issued the following news:
In a "Clinical Practice" review article in the New England Journal of Medicine, John Wysolmerski, MD, professor of medicine (endocrinology) at Yale School of Medicine provides a clinical update on hypercalcemia in malignancy, which often complicates the care of cancer patients.
"This is an update of a syndrome that led to the discovery of parathyroid hormone-re . . .
In a "Clinical Practice" review article in the New England Journal of Medicine, John Wysolmerski, MD, professor of medicine (endocrinology) at Yale School of Medicine provides a clinical update on hypercalcemia in malignancy, which often complicates the care of cancer patients.
"This is an update of a syndrome that led to the discovery of parathyroid hormone-re . . .